Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

New HCC Medication: Pembrolizumab

Friday 01 November 2019

We have added a new hepatic indication, hepatocellular carcinoma (HCC). The first drug for this indication, the humanised monoclonal antibody pembrolizumab (Keytruda®), has been added to the checker. A PK factsheet for pembrolizumab is available in the Prescribing Resources. Other medications for HCC will be added to the interaction checker soon.

SPONSORS
Sponsor logo janssen Sponsor logo gilead Sponsor logo msd Sponsor logo abbvie
EDITORIAL SPONSORS
Easl logo 2015
Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017 building_better_healthcare_awards_2016